Advanced search
Publication Cover
Bioscience, Biotechnology, and Biochemistry Volume 71, 2007 - Issue 9
Journal homepage
305
Views
40
CrossRef citations to date
0
Altmetric
Original Articles

Induction of Egr-1 Is Associated with Anti-Metastatic and Anti-Invasive Ability of β-Lapachone in Human Hepatocarcinoma Cells

Sung Ok KIMDepartment of Biomaterial Control (BK21 Program), Dongeui University Graduate School, Dongeui University College of Oriental Medicine
,
Jae Im KWONDepartment of Biochemistry, Dongeui University College of Oriental Medicine
,
Yong Kee JEONGCollege of Natural Resources and Life Science, Dong-A University
,
Gi Young KIMFaculty of Applied Marine Science, Cheju National University
,
Nam Deuk KIMDivision of Pharmacy (BK21 Program), Pusan National University, Research Institute for Drug Development
&
Yung Hyun CHOIDepartment of Biomaterial Control (BK21 Program), Dongeui University Graduate School, Dongeui University College of Oriental Medicine;Department of Biochemistry, Dongeui University College of Oriental Medicine
Pages 2169-2176 | Received 21 Feb 2007, Accepted 07 Jun 2007, Published online: 22 May 2014

  • 1) Baek, S. J., Kim, J. S., Moore, S. M., Lee, S. H., Martinez, J., and Eling, T. E., Cyclooxygenase inhibitors induce the expression of the tumor suppressor gene EGR-1, which results in the up-regulation of NAG-1, an antitumorigenic protein. Mol. Pharmacol., 67, 356–364 (2005).
  • 2) Shingu, T., and Bornstein, P., Overlapping Egr-1 and Sp1 sites function in the regulation of transcription of the mouse thrombospondin 1 gene. J. Biol. Chem., 269, 32551–32557 (1994).
  • 3) Liu, C., Yao, J., Mercola, D., and Adamson, E., The transcription factor EGR-1 directly transactivates the fibronectin gene and enhances attachment of human glioblastoma cell line U251. J. Biol. Chem., 275, 20315–20323 (2000).
  • 4) Castle, V. P., Dixit, V. M., and Polverini, P. J., Thrombospondin-1 suppresses tumorigenesis and angiogenesis in serum- and anchorage-independent NIH 3T3 cells. Lab. Invest., 77, 51–61 (1997).
  • 5) Weinstat-Saslow, D. L., Zabrenetzky, V. S., VanHoutte, K., Frazier, W. A., Roberts, D. D., and Steeg, P. S., Transfection of thrombospondin 1 complementary DNA into a human breast carcinoma cell line reduces primary tumor growth, metastatic potential, and angiogenesis. Cancer Res., 54, 6504–6511 (1994).
  • 6) Jimenez, B., Volpert, O. V., Crawford, S. E., Febbraio, M., Silverstein, R. L., and Bouck, N., Signals leading to apoptosis-dependent inhibition of neovascularization by thrombospondin-1. Nat. Med., 6, 41–48 (2000).
  • 7) de Fraipont, F., Nicholson, A. C., Feige, J. J., and Van Meir, E. G., Thrombospondins and tumor angiogenesis. Trends Mol. Med., 7, 401–407 (2001).
  • 8) Lawler, J., Thrombospondin-1 as an endogenous inhibitor of angiogenesis and tumor growth. J. Cell. Mol. Med., 6, 1–12 (2002).
  • 9) Yao, L., Zhao, Y. L., Itoh, S., Wada, S., Yue, L., and Furuta, I., Thrombospondin-1 expression in oral squamous cell carcinomas: correlations with tumor vascularity, clinicopathological features and survival. Oral Oncol., 36, 539–544 (2000).
  • 10) Woodhouse, E. C., Chuaqui, R. F., and Liotta, L. A., General mechanisms of metastasis. Cancer, 80, 1529–1537 (1997).
  • 11) Battle, E., Sancho, E., Franci, C., Dominguez, D., Monfar, M., Braulidia, J., and Herreros, A. G., The transcription factor Snail is a repressor of E-cadherin gene expression in epithelial tumor cells. Nat. Cell Biol., 2, 84–89 (2000).
  • 12) Yokoyama, K., Kamata, N., Hayashi, E., Hoteiya, T., Ueda, N., Fujimoto, R., and Ngayama, M., Reverse correlation of E-cadherin and snail expression in oral squamous cell carcinoma cells in vitro. Oral Oncol., 37, 65–71 (2001).
  • 13) Jiao, K., Miyazaki, K., and Kitajima, Y., Inverse correlation of E-cadherin and Snail expression in hepatocellular cell lines in vitro and in vivo. Br. J. Cancer, 86, 98–101 (2002).
  • 14) Poser, I., Dominguez, D., Herreros, A. G., Varnai, A., Buettner, R., and Bosserhoff, A., Loss of E-cadherin expression in melanoma cells involves up-regulation of the transcriptional repression Snail. J. Biol. Chem., 276, 24661–24666 (2001).
  • 15) Huber, M. A., Kraut, N., and Beug, H., Molecular requirements for epithelial-mesenchymal transition during tumor progression. Curr. Opin. Cell Biol., 17, 548–558 (2005).
  • 16) Nieto, M. A., The snail superfamily of zinc-finger transcription factors. Nat. Rev. Mol. Cell. Biol., 3, 155–166 (2002).
  • 17) Luo, J., Lubaroff, D. M., and Hendrix, M. J., Suppression of prostate cancer invasive potential and matrix metalloproteinase activity by E-cadherin transfection. Cancer Res., 59, 3552–3556 (1999).
  • 18) Oka, H., Shiozaki, H., Kobayashi, K., Inoue, M., Tahara, H., Kobayashi, T., Takatsuka, Y., Matsuyoshi, N., Hirano, S., and Takeichi, M., Expression of E-cadherin cell adhesion molecules in human breast cancer tissues and its relationship to metastasis. Cancer Res., 53, 1696–1701 (1993).
  • 19) Graff, J. R., Herman, J. G., Lapidus, R. G., Chopra, H., Xu, R., Jarrard, D. F., Isaacs, W. B., Pitha, P. M., Davidson, N. K., and Baylin, S. B., E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas. Cancer Res., 55, 5195–5199 (1995).
  • 20) Schaffner-Sabba, K., Schmidt-Ruppin, K. H., Wehrli, W., Schuerch, A. R., and Wasley, J. W., β-Lapachone: synthesis of derivatives and activities in tumor models. J. Med. Chem., 27, 990–994 (1984).
  • 21) Lopes, J. N., Cruz, F. S., Docampo, R., Vasconcellos, M. S., Sampaio, M. C., and Pinto, A. V., In vitro and in vivo evaluation of the toxicity of 1,4-naphthoquinone and 12-naphthoquinone derivatives against Trypanosoma cruzi. Ann. Trop. Med. Parasitol., 72, 523–531 (1978).
  • 22) Guiraud, P., Steiman, R., Campos-Takaki, G. M., Seigle-Murandi, F., and Simeon de Buochberg, M., Comparison of antibacterial and antifungal activities of lapachol and β-lapachone. Planta Med., 60, 373–374 (1994).
  • 23) Cruz, F. S., Docampo, R., and Boveris, A., Generation of superoxide anions and hydrogen peroxide from β-lapachone in bacteria. Antimicrob. Agents Chemother., 14, 630–633 (1978).
  • 24) Docampo, R., Cruz, F. S., Boveris, A., Muniz, R. P., and Esquivel, D. M., β-Lapachone enhancement of lipid peroxidation and superoxide anion and hydrogen peroxide formation by sarcoma 180 ascites tumor cells. Biochem. Pharmacol., 28, 723–728 (1979).
  • 25) Planchon, S. M., Pink, J. J., Tagliarino, C., Bornmann, W. G., Varnes, M. E., and Boothman, D. A., β-Lapachone-induced apoptosis in human prostate cancer cells: involvement of NQO1/xip3. Exp. Cell Res., 267, 95–106 (2001).
  • 26) Wuerzberger, S. M., Pink, J. J., Planchon, S. M., Byers, K. L., Bornmann, W. G., and Boothman, D. A., Induction of apoptosis in MCF-7:WS8 breast cancer cells by β-lapachone. Cancer Res., 58, 1876–1885 (1998).
  • 27) Huang, L., and Pardee, A. B., β-Lapachone induces cell cycle arrest and apoptosis in human colon. cancer cells. Mol. Med., 5, 711–720 (1999).
  • 28) Don, M. J., Chang, Y. H., Chen, K. K., Ho, L. K., and Chau, Y. P., Induction of CDK inhibitors (p21 (WAF1) and p27 (Kip1)) and Bak in the β-lapachone-induced apoptosis of human prostate cancer cells. Mol. Pharmacol., 59, 784–794 (2001).
  • 29) Li, Y., Sun, X., LaMont, J. T., Pardee, A. B., and Li, C. J., Selective killing of cancer cells by β-lapachone: direct checkpoint activation as a strategy against cancer. Proc. Natl. Acad. Sci. USA, 100, 2674–2678 (2003).
  • 30) Choi, Y. H., Kim, M. J., Lee, S. Y., Lee, Y. N., Chi, G. Y., Eom, H. S., Kim, N. D., and Choi, B. T., Phosphorylation of p53, induction of Bax and activation of caspases during β-lapachone-mediated apoptosis in human prostate epithelial cells. Int. J. Oncol., 21, 1293–1299 (2002).
  • 31) Choi, Y. H., Kang, H. S., and Yoo, M. A., Suppression of human prostate cancer cell growth by β-lapachone via inhibition of pRB phosphorylation and induction of Cdk inhibitor p21. J. Biochem. Mol. Biol., 36, 223–229 (2002).
  • 32) Choi, B. T., Cheong, J., and Choi, Y. H., β-Lapachone-induced apoptosis is associated with activation of caspase-3 and inactivation of NF-κB in human colon cancer HCT-116 cells. Anticancer Drugs, 14, 845–850 (2003).
  • 33) Woo, H. J., and Choi, Y. H., Growth inhibition of A549 human lung carcinoma cells by β-lapachone through induction of apoptosis and inhibition of telomerase activity. Int. J. Oncol., 26, 1017–1023 (2005).
  • 34) Bandyopadhyay, S., Wang, Y., Zhan, R., Pai, S. K., Watabe, M., Iiizumi, M., Furuta, E., Mohinta, S., Liu, W., Hirota, S., Hosobe, S., Tsukada, T., Miura, K., Takano, Y., Saito, K., Commes, T., Piquemal, D., Hai, T., and Watabe, K., The tumor metastasis suppressor gene Erg-1 down-regulates the expression of activating transcription factor 3 in prostate cancer. Cancer Res., 66, 11983–11990 (2006).
  • 35) Moon, Y., Bottone, F. G., Jr., McEntee, M. F., and Eling, T. E., Suppression of tumor cell invasion by cyclooxygenase inhibitors is mediated by thrombospondin-1 via the early growth response gene. Mol. Cancer Ther., 4, 1551–1558 (2005).
  • 36) Miyoshi, A., Kitajima, Y., Kido, S., Shimonishi, T., Matsuyama, S., Kitahara, K., and Miyazaki, K., Snail accelerates cancer invasion by upregulating MMP expression and is associated with poor prognosis of hepatocellular carcinoma. Br. J. Cancer, 92, 252–258 (2005).
  • 37) Zhang, J. F., Zhang, Y. P., Hao, F. Y., Zhang, C. X., Li, Y. J., and Ji, X. R., DNA ploidy analysis and expression of MMP-9, TIMP-2, and E-cadherin in gastric carcinoma. World J. Gastroenterol., 11, 5592–5600 (2005).
  • 38) Howard, E. M., Lau, S. K., Lyles, R. H., Birdsong, G. G., Tadros, T. S., Umbreit, J. N., and Kochhar, R., Correlation and expression of p53, HER-2, vascular endothelial growth factor (VEGF), and E-cadherin in a high-risk breast-cancer population. Int. J. Clin. Oncol., 9, 154–160 (2004).
  • 39) Grotegut, S., von Schweinitz, D., Christofori, G., and Lehembre, F., Hepatocyte growth factor induces cell scattering through MAPK/Egr-1-mediated upregulation of Snail. EMBO J., 25, 3534–3545 (2006).
  • 40) Barrallo-Gimeno, A., and Nieto, M. A., The Snail genes as inducers of cell movement and survival: implications in development and cancer. Development, 132, 3151–3161 (2005).
  • 41) Peiro, S., Escriva, M., Puig, I., Barbera, M. J., Dave, N., Herranz, N., Larriba, M. J., Takkunen, M., Franci, C., Munoz, A., Virtanen, I., Baulida, J., and Garcia de Herreros, A., Snail1 transcriptional repressor binds to its own promoter and controls its expression. Nucleic Acids Res., 34, 2077–2084 (2006).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.